Albireo Dashes Into PFIC Market As FDA, EMA Approve Bylvay

 
• By Alaric DeArment
liver
Albireo is aiming to launch Bylvay immediately in the US, targeting around 100 physicians at 60 centers • Source: Shutterstock

More from Rare Diseases

More from Scrip